Please use this identifier to cite or link to this item: https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13025
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGu, Y.-
dc.contributor.authorPham, J. P.-
dc.contributor.authorSebaratnam, D. F.-
dc.date.accessioned2024-09-02T05:57:23Z-
dc.date.available2024-09-02T05:57:23Z-
dc.date.issued2024-
dc.identifier.issn0909752X (ISSN)-
dc.identifier.urihttps://swslhd.intersearch.com.au/swslhdjspui/handle/1/13025-
dc.publisherJohn Wiley and Sons Inc-
dc.subjectDrug Repositioning GTP-Binding Protein alpha Subunits, Gq-G11 Humans Precision Medicine Protein Kinase C Protein Kinase Inhibitors Vascular Malformations protein kinase C inhibitor GNAQ protein, human guanine nucleotide binding protein alpha subunit protein kinase inhibitor congenital blood vessel malformation gene gna11 gene gnaq gene human Letter personalized medicine phakomatosis somatic mutation drug therapy genetics pathology-
dc.titleTowards precision medicine in vascular anomalies: Could protein kinase C inhibitors be repurposed for GNAQ/11-related phakomatoses?-
dc.typeJournal Article-
dc.description.affiliatesFaculty of Medicine, University of New South Wales, Kensington, NSW, Australia Department of Dermatology, Liverpool Hospital, Liverpool, NSW, Australia Laboratory of Translational Cutaneous Medicine, Ingham Institute of Applied Medical Research, Liverpool, NSW, Australia-
dc.identifier.doi10.1111/srt.13736-
dc.type.studyortrialLetter-
dc.identifier.journaltitleSkin Research and Technology-
Appears in Collections:Liverpool Hospital

Files in This Item:
There are no files associated with this item.


Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing